Award Data

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to improve the way educators and therapists teach social skills to children who are on the autism spectrum (as well as those affected by other social skills disorders) and deliver cost efficiencies that could expand access to such support across diverse socioeconomic classes and geographica ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is the development of a digital skeletal evaluation workflow for reproductive toxicology studies that will better ensure that potential therapeutics with teratogenic effects will not make it to the marketplace, and at reduced time and cost. The current approach for characterizing the impact of new the ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project will be to develop protein purification nanotechnology and materials for biopharmaceutical applications. Over 150 different protein or small peptide-based drugs have received FDA approval to treat an array of diseases (e.g., biologics, monoclonal antibodies, and blood clotting factors). Protein purifi ...

This Small Business Innovation Research Phase I project will result in the development of smart, self-healing nanocapsules as anticorrosive pigment additive for commercialization of sustainable, economical and metal free acrylic, epoxy or polyurethane based anticorrosive coatings. The nanocapsule additive based anticorrosive coating will meet and exceed the performance of solvent and heavy metals ...

This SBIR Phase I project seeks to transform treatment regimens for individuals suffering from malaria infections. Malaria, particularly caused by Plasmodium vivax (P. vivax) and Plasmodium ovale (P. ovale) remain a potential cause of morbidity and mortality amongst the 2.85 billion people living at risk of infection. The only drug currently available for treatment therapy for P. vivax and P. oval ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is an improvement in how artificial limbs (prostheses) are fitted to the individual user. This promises better rehabilitation outcomes for people with limb loss, which lowers the risk of long-term health issues, such as accidental falls, back pain, or conditions that are associated with a sede ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to provide clinical decision support software that assists inpatient providers in improving care for preventable acute inpatient harms, and thereby reduce mortality and morbidity. This grant develops a cloud-based platform that applies machine learning (ML) algorithms in real-time on data e ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the restoration of trust in computing systems. Successful cyberattacks, including mass privacy breaches and the discovery of device backdoors, have shaken trust in computing, put users at risk, hurt the economy, and even threatened our national security. The usual set of ad-hoc, incomplete, ...

This SBIR Phase I project is intended to develop a noninvasive, ultra-sensitive molecular detection system for Tuberculosis (TB). Although the prevalence of TB has diminished, it still remains the second leading cause of death from an infectious disease. The latest global TB report from the World Health Organization with data compiled from 205 countries put the figures at 1.5 million fatalities an ...

The broader impact/commercial potential of this project is to enable real-time situational awareness in autonomous vehicles. With the global population expected to reach 9 billion by 2050 and the uncertain climate changes that create concern over the resources allocated to farming activities, precision agriculture has become the ultimate solution to increase agricultural productivity and efficienc ...